Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(a)(6) CONSULTING AGREEMENTConsulting Agreement • April 25th, 2024 • Kiniksa Pharmaceuticals, Ltd. • Pharmaceutical preparations • New York
This Consulting Agreement (the “Agreement”) is made as of November 3, 2023 (the “Effective Date”) by and between Kiniksa Pharmaceuticals, Ltd., a Bermuda exempted company with a business address at Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda (“Kiniksa”), and Dr. Richard S. Levy with an address at [***] (“Consultant”).
